Free Trial

bluebird bio (BLUE) Earnings Date, Estimates & Call Transcripts

bluebird bio logo
$0.29 -0.01 (-3.63%)
(As of 10:15 AM ET)

bluebird bio Latest Earnings Summary

Latest Q2 2024
Earnings Date
Sep. 27Estimated
Actual EPS
(Sep. 27)
-$0.42 Missed By -$0.02
Consensus EPS
(Sep. 27)
-$0.40

bluebird bio posted Q2 2024 earnings on September 27, 2024, reporting an EPS of -$0.42, which missed the consensus estimate of -$0.40 by $0.02. Quarterly revenue was reported to be $16.10 million, above analysts' expectations of $16.09 million. With a trailing EPS of -$1.87, bluebird bio's earnings are expected to grow next year, from ($1.35) to ($0.41) per share.

Get bluebird bio Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on bluebird bio and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

BLUE Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BLUE Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

bluebird bio Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20244-$0.69-$0.29-$0.53
Q2 20244-$0.69-$0.33-$0.51
Q3 20244-$0.58-$0.39-$0.47
Q4 20244-$0.50-$0.22-$0.40
FY 202416-$2.46-$1.23-$1.90
Q1 20254-$0.38-$0.07-$0.24
Q2 20254-$0.33-$0.05-$0.17
Q3 20254-$0.36$0.01-$0.15
Q4 20254-$0.51-$0.04-$0.23
FY 202516($1.58)($0.15)($0.79)

bluebird bio Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
9/27/2024Q2 2024-$0.40-$0.42 -$0.02-$0.42$16.09M$16.10M
9/13/2024Q1 2024--$0.36 -$0.36-$0.36-$18.57M
11/7/2023Q3 2023-$0.69-$0.66+$0.03-$0.66$13.56M$12.40M        
8/8/2023Q2 2023-$0.72-$0.67+$0.05-$0.67$11.30M$6.90M          
5/9/2023Q1 2023-$0.54$0.21+$0.75$0.21$26.97M$2.40M    
3/29/2023Q4 2022-$0.45$0.38+$0.83$0.38$102.24M$0.06M

bluebird bio Earnings - Frequently Asked Questions

bluebird bio (NASDAQ:BLUE) last announced its quarterly earning data on Friday, September 27, 2024. Learn more on BLUE's earnings history.

bluebird bio updated its fourth quarter 2024 earnings guidance on Thursday, November, 14th. The company issued revenue guidance of $25.0 million-, compared to the consensus revenue estimate of $29.4 million.

In the previous quarter, bluebird bio (NASDAQ:BLUE) missed the analysts' consensus estimate of ($0.40) by $0.02 with a reported earnings per share (EPS) of ($0.42). Learn more on analysts' earnings estimate vs. BLUE's actual earnings.

bluebird bio (NASDAQ:BLUE) has a recorded annual revenue of $29.50 million.

bluebird bio (NASDAQ:BLUE) has a recorded net income of -$211.91 million. BLUE has generated -$1.87 earnings per share over the last four quarters.

bluebird bio's earnings are expected to grow from ($1.35) per share to ($0.41) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:BLUE) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners